Abstract
Gastric cancer (GC) is one of the most common malignancies worldwide. Multidisciplinary strategies including chemotherapy, radiotherapy and surgical resection are the basic treatment for stomach cancer and significantly improve the survival of patients with GC. However, the prognosis of patients with advanced GC remains poor. The high risk of disease relapse prompted the investigation of genomic factors which could be the predictive or prognostic biomarkers of GC. Thus, we established a multi-gene prognostic model for predicting the prognosis of GC and explored crucial molecular mechanisms associated with prognostic lncRNA expression signature.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
